Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Limitations of Cross-Trial Comparisons While retatrutides 28% threshold outpaces tirzepatides 22.5% threshold, medical researchers exercise caution when making direct comparisons
The proportion of lean mass loss to total weight loss with Retatrutide was consistent with other obesity treatments, meaning that despite achieving substantially greater total weight loss, participants did not sacrifice a disproportionate amount of muscle tissue
Introductory rates that jump sharply after the first cycle are common across the market, so the sustainable monthly figure matters more than the teaser
Retatrutide is not available by prescription today, and it is not approved in any form
This matters for patients with nonalcoholic fatty liver disease (NAFLD) a common comorbidity in type 2 diabetes and reflects retatrutide's broader metabolic impact beyond glucose and weight
